These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 6284965)
1. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. Eisenberg RJ; Ponce de Leon M; Pereira L; Long D; Cohen GH J Virol; 1982 Mar; 41(3):1099-1104. PubMed ID: 6284965 [TBL] [Abstract][Full Text] [Related]
2. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583 [TBL] [Abstract][Full Text] [Related]
3. Amino-terminal sequence of glycoprotein D of herpes simplex virus types 1 and 2. Eisenberg RJ; Long D; Hogue-Angeletti R; Cohen GH J Virol; 1984 Jan; 49(1):265-8. PubMed ID: 6317892 [TBL] [Abstract][Full Text] [Related]
4. Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2. Cohen GH; Long D; Matthews JT; May M; Eisenberg R J Virol; 1983 Jun; 46(3):679-89. PubMed ID: 6304338 [TBL] [Abstract][Full Text] [Related]
5. Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D. Dietzschold B; Eisenberg RJ; Ponce de Leon M; Golub E; Hudecz F; Varrichio A; Cohen GH J Virol; 1984 Nov; 52(2):431-5. PubMed ID: 6208376 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403 [TBL] [Abstract][Full Text] [Related]
7. Production and characterization of an anti-idiotypic antibody specific for a monoclonal antibody to glycoprotein D of herpes simplex virus. Lathey JL; Rouse BT; Wiley DE; Courtney RJ Immunology; 1986 Jan; 57(1):29-35. PubMed ID: 3002969 [TBL] [Abstract][Full Text] [Related]
8. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge. Roberts PL; Duncan BE; Raybould TJ; Watson DH J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080 [TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinants. Zweig M; Showalter SD; Bladen SV; Heilman CJ; Hampar B J Virol; 1983 Jul; 47(1):185-92. PubMed ID: 6191040 [TBL] [Abstract][Full Text] [Related]
10. Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2. Eisenberg RJ; Ponce de Leon M; Cohen GH J Virol; 1980 Aug; 35(2):428-35. PubMed ID: 6255183 [TBL] [Abstract][Full Text] [Related]
11. Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. Eisenberg RJ; Long D; Pereira L; Hampar B; Zweig M; Cohen GH J Virol; 1982 Feb; 41(2):478-88. PubMed ID: 6176725 [TBL] [Abstract][Full Text] [Related]
12. Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies. Koga J; Chatterjee S; Whitley RJ Virology; 1986 Jun; 151(2):385-9. PubMed ID: 3010559 [TBL] [Abstract][Full Text] [Related]
13. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713 [TBL] [Abstract][Full Text] [Related]
14. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. Para MF; Parish ML; Noble AG; Spear PG J Virol; 1985 Aug; 55(2):483-8. PubMed ID: 2991571 [TBL] [Abstract][Full Text] [Related]
15. Isolation by high-performance liquid chromatography and partial characterization of a 57,000-dalton herpes simplex virus type 1 polypeptide. Welling-Wester S; Popken-Boer T; Wilterdink JB; van Beeumen J; Welling GW J Virol; 1985 May; 54(2):265-70. PubMed ID: 2985795 [TBL] [Abstract][Full Text] [Related]
16. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. Fuller AO; Spear PG J Virol; 1985 Aug; 55(2):475-82. PubMed ID: 2991570 [TBL] [Abstract][Full Text] [Related]
17. Localization of epitopes of herpes simplex virus type 1 glycoprotein D. Eisenberg RJ; Long D; Ponce de Leon M; Matthews JT; Spear PG; Gibson MG; Lasky LA; Berman P; Golub E; Cohen GH J Virol; 1985 Feb; 53(2):634-44. PubMed ID: 2578577 [TBL] [Abstract][Full Text] [Related]
18. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization. Minson AC; Hodgman TC; Digard P; Hancock DC; Bell SE; Buckmaster EA J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to a synthetic oligopeptide that react with herpes simplex virus type 1 and 2 glycoprotein C. Zweig M; Showalter SD; Simms DJ; Hampar B J Virol; 1984 Aug; 51(2):430-6. PubMed ID: 6086954 [TBL] [Abstract][Full Text] [Related]
20. The properties and sequence of glycoprotein H of herpes simplex virus type 1. Gompels U; Minson A Virology; 1986 Sep; 153(2):230-47. PubMed ID: 3016991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]